Mass Composting of Swine Slurry
This project will address several concerns related to composting slurry/manure.
Research is at the heart of the National Pork Board’s mission and is funded by your Pork Checkoff dollars. Research is administered in all areas of pork production, processing, and human nutrition to develop a higher quality and more profitable product in the competitive meat protein market.
Learn more about how you can help advance the pork industry through ongoing research.
This project will address several concerns related to composting slurry/manure.
This study was to evaluate the ability of the vaccine to be lyophilized, and the stability of the vaccine under different storage conditions.
Overall, this study provides data on novel diagnostic sample types in a unique natural consumption model with potential benefits towards enhanced surveillance and early ASFV detection.
In this study we aimed to identify proteins in ASFV using serum containing antibodies from animals with live-attenuated vaccinated animals, that could be used as targets for a serological assay to differentiate between vaccinated and infected animals, these identified proteins were attempted to be deleted from a field isolate of highly pathogenic ASFV, to determine if they could be deleted.
The purpose of this literature review was to identify the pathways by which feral swine might transmit ASFV to domestic pigs in the US.
This project addresses the need to develop and validate a CSF diagnostic test with DIVA capabilities, and improving specificity and sensitivity compared to current methods.
The objectives of this review are to describe the current knowledge of ASFV survival in raw materials used to produce porcine-based ingredients, identify priorities for future research, and summarize potential options for managing risk until additional knowledge can be gained.
The objective of this project was to evaluate commercially available disinfectants and disinfection application methods against PEDV and PRRSV on various surfaces within semi-truck cabs including assessment of viral infectivity using a swine bioassay model.
Partnering to expand testing capacities, support further evaluation and validation of two commercially available CSF PCR assays, and enhance preparedness across the NAHLN.
In this study, we aim to explore the potential of mRNA vaccine technology for the development of a subunit vaccine against ASFV. For this pilot project, we focused on assessing the immunogenicity of mRNA vaccines containing four well-characterized ASFV antigens: p32, p54, C-type lectin, and CD2v. Each of these antigens plays a distinct role in the viral lifecycle.